Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00063336 |
This study will examine the ways in which schizophrenia-related symptoms affect response to a rehabilitation program for people with schizophrenia.
Condition |
---|
Schizophrenia |
Study Type: | Observational |
Study Design: | Psychosocial, Longitudinal, Defined Population, Prospective Study |
Official Title: | Treatment Response to Rehabilitation in Schizophrenia |
Patients with schizophrenia often suffer neurocognitive impairment and psychosocial and vocational difficulties. This study will help identify those patients most likely to benefit from existing behavioral treatments and provide clues for how to modify treatments for those who do not benefit.
Two studies will be conducted. The first will investigate the relationship of symptoms and neurocognitive variables at study entry to psychosocial and vocational status 2 years later. The second study will investigate the relationship of symptoms and neurocognitive variables at study entry to treatment response in patients assigned to either a cognitive remediation track or a computer skills track as part of their rehabilitation treatment.
Both the cognitive remediation and computer skills training programs will last 4 to 6 months. Participants will be assessed pre- and post-treatment. Neuropsychological, psychosocial and vocational status will be measured.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Connecticut | |
Schizophrenia Rehabilitation Program, Institutes of Living | Recruiting |
Hartford, Connecticut, United States, 06106 | |
Contact: Matthew M. Kurtz, PhD 860-545-7304 mkurtz@harthosp.org |
Study ID Numbers: | R03 MH65377, DSIR AT-SP |
Study First Received: | June 25, 2003 |
Last Updated: | November 17, 2005 |
ClinicalTrials.gov Identifier: | NCT00063336 |
Health Authority: | United States: Federal Government |
Schizophrenia Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |